The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

The randomized, double-blind, placebo-controlled ODYSSEY-HCM trial included 580 adult patients with symptomatic nonobstructive HCM.

To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and promote the use of lab-grown human organoids (tiny, self-organized ...

When used with the companion app, the smart belt automatically alerts caregivers when a fall or impact is detected.

In the past, experts from the CDC’s EpiAid program have provided short-term help to local agencies dealing with urgent public health issues.

The recall involves the "Brunch & Go" stroller toy, a set of make-believe breakfast items including avocado toast, bacon, a tomato and an egg.

CJD is caused by infectious proteins called prions. These proteins damage the brain and lead to fast-moving dementia.

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

Seventy-four percent of respondents unaware of FDA-approved treatments; 56% said these options had not been discussed by clinician.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.